Kidney patients are less likely to get the suggested medications after undergoing heart attack, a new study suggests.

According to this report that will be published in the September issue of the Clinical Journal of the American Society of Nephrology  demonstrates that dialysis are required to end-stage renal disease patients and they are not given heart-saving medicines like beta blockers and other cholesterol-lowering medicines.

“Kidney disease is considered an established risk factor for heart attack and other cardiovascular diseases and it also serves as an indicator for such events” stated Wolfgang C. Winkelmayer, of Brigham and Women’s Hospital, in Boston in a news release.

The data on medication use after a heart attack was analyzed by the researchers, the data related to almost 21,500 patients and most of them had kidney disease. The researchers adjusted other factors and found that patient with chronic kidney disease were 22 percent less apt to commence a beta blocker treatment. While patient with end-stage renal disease were 43 percent less likely to offer angiotensin-converting enzyme and other blockers.

Besides aspirin these three drugs are reckoned quite important to avoid cardiovascular issues that lead to heart attack.

The researchers stress on new ways to cut the risk of cardiovascular problems among kidney patients as the risks of kidney disease is getting bigger and bigger with every passing day.

Related links

•  Kidney Patients Less Likely to Get Heart Attack

This article is the property of http://www.healthpm.com
Copying and publishing any article from our site is strictly NOT allowed